Zealand Pharma (NASDAQ:ZEAL) reported its Q4 earnings results on Thursday, March 10, 2022 at 08:00 AM.
Here's what investors need to know about the announcement.
Earnings
Zealand Pharma missed estimated earnings by 7.53%, reporting an EPS of $-1.0 versus an estimate of $-0.93.
Revenue was down $292.00 thousand from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.26 which was followed by a 9.37% drop in the share price the next day.
Here's a look at Zealand Pharma's past performance:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | -0.99 | -0.92 | -1.01 | -0.94 |
| EPS Actual | -0.73 | -1.11 | -0.94 | -1.41 |
| Revenue Estimate | 11.09M | 10.76M | 9.89M | 18.52M |
| Revenue Actual | 16.88M | 13.66M | 7.50M | 8.60M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
